Intellectual Property > Nova Content
By Christopher Hall
Here is a technique for rapidly drafting claims, for a patent application. This is a brainstorming mechanism that works for one person, or... Read More »
By Barry Herman
By now, most everyone in the patent community has heard about the $2.54 Billion dollar jury verdict in a battle over Hepatitis C medication that... Read More »
I have both been busy since the holiday season and frankly, uninspired by the case law that has appeared on the scene. Who can be enraptured by the fine points of... Read More »
Written by Daniel A. Kamkar and Eric Furman, Ph.D.
After the United Kingdom voted to leave the European Union, dubbed “Brexit” by the press, many have ... Read More »
Written by Robert J. Hilton, Ph.D. and Bryan McWhorter
The Federal Circuit recently found claims to a specialized graphical user interface (GUI) for trading... Read More »
Written by Robert J. Hilton, Ph.D. and Jing Liu, Ph.D.
On January 13, 2017, the Supreme Court granted certiorari in Amgen v. Sandoz, 794. f. 3d 1347 (Fed. Cir... Read More »
A patentee has several options for responding to a Petition for Inter Partes Review (“IPR”) or Covered Business Method (“CBM”) petition. The... Read More »
Last week we reported on the top 10 all-time IPR petitioners and learned that Apple, with 267 IPR challenges filed from 2012 through 2016, was at the top. This... Read More »
Written by Jeffrey C. Wu, Ph.D. and Kerry S. Taylor, Ph.D.
In Covidien LP v. University of Florida Research Foundation Incorporated, IPR2016-01274, -01275... Read More »
Written by Peter Heuser, Schwabe Williamson & Wyatt
In Tinnus v. Telebrands, the Circuit affirms the grant of a preliminary injunction even though... Read More »
Written by Marc Chatenay-Lapointe, Ph.D. and Chrisopher M. DiLeo
The Federal Circuit’s recent decision in Apple, Inc. v. Ameranth, Inc. highlights the... Read More »
Inventions directed to “pure software” have arguably had the most difficult time surviving Alice challenges. Software is often characterized as an... Read More »
A few weeks ago we reported a sharp decline in patent litigation in 2016 of more than 20 percent. However, activity for Inter-Partes Review (IPR) remained basically... Read More »
Written by Peter Law, Jason J. Jardine and Loni Morrow
On January 5, 2017, Skechers U.S.A., Inc. filed a petition with the Patent Trial and Appeal Board to... Read More »
Written by Kerry S. Taylor, Ph.D. and Michael L. Fuller
On January 19, 2017, the Board issued a final written decision in World Bottling Cap, LLC v Crown... Read More »
Before turning to 2017 news, we’ll first briefly catch up on a few stories from December.
In early December, the Brazilian green patent priority... Read More »
The doctrine of definiteness requires a patent to clearly state what the inventor considers to be their invention. Of course, the PTAB interprets various claim terms... Read More »
Written by Paul Chang, Ph.D. and Brenden Gingrich, Ph.D.
Anticipation by inherent disclosure requires that a single prior art reference necessarily includes the... Read More »
Last week we published patent litigation stats for 2016 as we learned that the numbers of District Court Cases had declined more than 20 percent compared to 2015... Read More »
Written by Marc Chatenay-Lapointe, Ph.D. and Michael L. Fuller
On December 23, 2016, the U.S. Food and Drug Administration approved SPINRAZA™ (nusinersen)... Read More »